Ceo, Founder
CurrentProviding advanced treatment options for depression and other disorders, with interventions including Transcranial Magnetic Stimulation (TMS), the SAINT protocol, and ketamine. By referral only. www.LATMS.com
Please complete the CAPTCHA to continue
@ucla.edu
✓
4 phones found area 310
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Ian A. Cook, Md Dlfapa Fctmss is listed as CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma. at Los Angeles TMS Institute, Inc., based in Los Angeles, California, United States. AeroLeads shows a work email signal at ucla.edu, phone signal with area code 310, and a matched LinkedIn profile for Ian A. Cook, Md Dlfapa Fctmss.
Ian A. Cook, Md Dlfapa Fctmss previously worked as CEO, Founder at Los Angeles Tms Institute, Inc. and Vice President, Founding Board Member at Foundation For The Advancement Of Clinical Tms. Ian A. Cook, Md Dlfapa Fctmss holds Md, Medicine from Yale School Of Medicine.
This section adds company-level context without repeating Ian A. Cook, Md Dlfapa Fctmss's masked contact details.
AeroLeads found 1 current-domain work email signal for Ian A. Cook, Md Dlfapa Fctmss. Compare company email patterns before reaching out.
Ian A. Cook, Md Dlfapa Fctmss is a CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma. at Los Angeles TMS Institute, Inc.. They possess expertise in neuroscience, clinical research, psychiatry, healthcare, treatment and 42 more skills. Colleagues describe them as "Dr. Cook has mastered the fusion of academic ingenuity, humility and collegial synergy. Present and future healthcare professionals can increase their positive influence by following his example."
Listed skills include Neuroscience, Clinical Research, Psychiatry, Healthcare, and 43 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Providing advanced treatment options for depression and other disorders, with interventions including Transcranial Magnetic Stimulation (TMS), the SAINT protocol, and ketamine. By referral only. www.LATMS.com
Brentwood, Tn, Us
Los Angeles, Ca, Us
Professor Emeritus July 2018 - Professor-in-Residence July 2010 - June 2018Associate Professor-in-Residence July 2003 - June 2010Assistant Professor-in-Residence July 1996 - June 2003Instructor July 1995 - June 1996* Innovating through translational neuroscience research* Promoting and providing evidence-based excellence in patient care* Teaching across multiple levels, from Continuing Education programs, to residents, medical students, undergraduates, and primary school students* Leading through administrative roles at the School of Medicine, in the Semel Institute, and in the Department of Psychiatry and Biobehavioral Sciences * See http://www.IanCook.com for details
Los Angeles, Ca, Us
Facilitate and accelerate the identification, development, and commercialization of discoveries from the Semel Institute
Los Angeles, Ca, Us
Founded this clinical service at UCLA, bringing this form of therapeutic neuromodulation to the UCLA community
NeuroSigma, Inc., is a Los Angeles-based life sciences company, established to develop neuromodulation technologies with the potential to transform medical practice and patients’ lives. The clinical focus has been neurological and neuropsychiatric disorders.Trigeminal Nerve Stimulation (TNS) is unique among neuromodulation therapies because it can be delivered via a non-invasive external trigeminal nerve stimulation (eTNS™) system, or a minimally-invasive subcutaneous trigeminal nerve stimulation (sTNS™) system. NeuroSigma is investigating TNS as a treatment for epilepsy, depression, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), Traumatic Brain Injury (TBI), and a rare, orphan disorder, Lennox-Gastaut Syndrome (LGS). One of the inventors of the core IP around TNS, I was Senior Medical Advisor to the company before becoming CMO and SVP in February 2014.Links to some representative activities:* PTSD http://t.co/7vU11T3uHB :: http://ucla.in/1PerckG :: http://bit.ly/22wxPve* ADHD http://mdgdgt.com/1lvcBu4* TBI http://bit.ly/1RJwsChCurrently on leave
Fresno, California, Us
"By pooling together resources and experience, the Clinical TMS Society aims to optimize the administration of TMS, develop novel indications for treatment, expand insurance coverage, and increase public awareness of TMS around the world." http://www.ClinicalTMSSociety.orgCo-Chair, Legal, Business, and Ethics Committee 2017 - present
Los Angeles, California, Us
CEO and Chairman, Board of Directors 2018 - 2023.CMO 2023 - 2024HeartCloud.io unleashes the rich data collected via wearables and at-home sensors, and provides Insights into health and fitness for clinicians to provide higher quality remote care, through Remote Physiologic Monitoring and Remote Therapeutic Monitoring. HeartCloud for Health Practices (practices.heartcloud.io) gives providers access to the data with visualizations that cut through the noise and guide them to the key information - for better informed decisions, made more efficiently and profitably.https://practices.heartcloud.io
Washington, Dc, Us
Working to deliver and improve mental health care for our Veterans
This program trains psychiatrists to provide state-of-the-art neuromodulation treatments, focusing on the principles and practice of FDA-approved neuromodulation systems and investigational approaches that are in research and development. http://TMSLosAngeles.com/forms/NSTPCallForApplicants.pdfDavid Krantz, MD, PhD, is our inaugural Scholar
Teaching and establishing research collaborations among groups at UCLA, with a focus on neuromodulation and bioelectrical signals.
Los Angeles, Ca, Us
Improve care for depression by (a) developing and improving new treatments such as new medications and neuromodulation methods (e.g., trigeminal nerve stimulation, transcranial magnetic stimulation (TMS)), (b) improving the use of current interventions such as using biomarkers to guide treatment planning, (c) catalyzing collaborative research in depression intramurally at UCLA and through extramural research partnering, (d) providing public education on depression and other mood disorders (twitter @moodresearch)
Los Angeles, Ca, Us
Renamed the UCLA Resnick Neuropsychiatric Hospital in 2004
Translational neuroscience research
Elected Representative of the School's Faculty for shared governance.
Develop biomarkers to help guide the optimal use of existing treatments, and develop new treatments for mood disorders
Washington, Dc, Us
Development and dissemination of evidence-based practice guidelines
Washington, Dc, Us
Oversee and coordinate the didactic program for Residents in Psychiatry at UCLA
T32 MH17140
Quick answers generated from the profile data available on this page.
Ian A. Cook, Md Dlfapa Fctmss works for Los Angeles TMS Institute, Inc..
Ian A. Cook, Md Dlfapa Fctmss is listed as CEO/Founder/Director, Los Angeles TMS Institute. Co-Founder & Past-CEO, HeartCloud.io. UCLA Professor Emeritus. CMO/SVP NeuroSigma. at Los Angeles TMS Institute, Inc..
AeroLeads has found 1 work email signal at @ucla.edu for Ian A. Cook, Md Dlfapa Fctmss at Los Angeles TMS Institute, Inc..
AeroLeads has found 4 phone signal(s) with area code 310 for Ian A. Cook, Md Dlfapa Fctmss at Los Angeles TMS Institute, Inc..
Ian A. Cook, Md Dlfapa Fctmss is based in Los Angeles, California, United States while working with Los Angeles TMS Institute, Inc..
Ian A. Cook, Md Dlfapa Fctmss has worked for Los Angeles Tms Institute, Inc., Foundation For The Advancement Of Clinical Tms, Ucla Health System, Neurosigma, Inc., and Clinical Tms Society.
You can use AeroLeads to view verified contact signals for Ian A. Cook, Md Dlfapa Fctmss at Los Angeles TMS Institute, Inc., including work email, phone, and LinkedIn data when available.
Ian A. Cook, Md Dlfapa Fctmss holds Md, Medicine from Yale School Of Medicine.
Ian A. Cook, Md Dlfapa Fctmss is listed with skills including Neuroscience, Clinical Research, Psychiatry, Healthcare, Treatment, Mental Health, Medicine, and Medical Education.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts